193 related articles for article (PubMed ID: 30107896)
1. Treatment outcomes and incidence of brain metastases in pulmonary large cell neuroendocrine carcinoma.
Zhao Y; Castonguay M; Wilke D; Xu Z; Plourde M; Mulroy L; MacNeil M; Bowes D
Curr Probl Cancer; 2019 Feb; 43(1):54-65. PubMed ID: 30107896
[TBL] [Abstract][Full Text] [Related]
2. Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice.
Metro G; Ricciuti B; Chiari R; Baretti M; Falcinelli L; Giannarelli D; Sidoni A; Mountzios G; Crinò L; Bellezza G; Rebonato A; Ferolla P; Toschi L
Lung Cancer; 2016 May; 95():82-7. PubMed ID: 27040856
[TBL] [Abstract][Full Text] [Related]
3. Disparity in clinical outcomes between pure and combined pulmonary large-cell neuroendocrine carcinoma: A multi-center retrospective study.
Zhang JT; Li Y; Yan LX; Zhu ZF; Dong XR; Chu Q; Wu L; Zhang HM; Xu CW; Lin G; Yu ZY; Hu J; Zhu B; Wang HJ; Yang F; Song ZB; Han ZB; Li MX; Lin J; Wu YL; Wang JL; Zhong WZ
Lung Cancer; 2020 Jan; 139():118-123. PubMed ID: 31775086
[TBL] [Abstract][Full Text] [Related]
4. Management of brain metastases from large cell neuroendocrine carcinoma of the lung: improved outcomes with radiosurgery.
Wegner RE; Hasan S; Williamson RW; Finley G; Fuhrer R; Colonias A; Karlovits SM
Acta Oncol; 2019 Apr; 58(4):499-504. PubMed ID: 30732516
[TBL] [Abstract][Full Text] [Related]
5. Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas.
Rieber J; Schmitt J; Warth A; Muley T; Kappes J; Eichhorn F; Hoffmann H; Heussel CP; Welzel T; Debus J; Thomas M; Steins M; Rieken S
Eur J Med Res; 2015 Aug; 20(1):64. PubMed ID: 26272455
[TBL] [Abstract][Full Text] [Related]
6. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
7. High-Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
Alese OB; Jiang R; Shaib W; Wu C; Akce M; Behera M; El-Rayes BF
Oncologist; 2019 Jul; 24(7):911-920. PubMed ID: 30482824
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with irinotecan and cisplatin for large-cell neuroendocrine carcinoma of the lung: a multicenter phase II study.
Niho S; Kenmotsu H; Sekine I; Ishii G; Ishikawa Y; Noguchi M; Oshita F; Watanabe S; Nakajima R; Tada H; Nagai K
J Thorac Oncol; 2013 Jul; 8(7):980-4. PubMed ID: 23774385
[TBL] [Abstract][Full Text] [Related]
9. Gamma Knife radiosurgery for brain metastases from pulmonary large cell neuroendocrine carcinoma: a Japanese multi-institutional cooperative study (JLGK1401).
Kawabe T; Yamamoto M; Sato Y; Yomo S; Kondoh T; Nagano O; Serizawa T; Tsugawa T; Okamoto H; Akabane A; Aita K; Sato M; Jokura H; Kawagishi J; Shuto T; Kawai H; Moriki A; Kenai H; Iwai Y; Gondo M; Hasegawa T; Yasuda S; Kikuchi Y; Nagatomo Y; Watanabe S; Hashimoto N
J Neurosurg; 2016 Dec; 125(Suppl 1):11-17. PubMed ID: 27903179
[TBL] [Abstract][Full Text] [Related]
10. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
11. Large cell neuroendocrine carcinoma of the lung: a 10-year clinicopathologic retrospective study.
Paci M; Cavazza A; Annessi V; Putrino I; Ferrari G; De Franco S; Sgarbi G
Ann Thorac Surg; 2004 Apr; 77(4):1163-7. PubMed ID: 15063227
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of Curative-Intent Surgery and Adjuvant Treatment for Pulmonary Large Cell Neuroendocrine Carcinoma.
Kim KW; Kim HK; Kim J; Shim YM; Ahn MJ; Choi YL
World J Surg; 2017 Jul; 41(7):1820-1827. PubMed ID: 28204910
[TBL] [Abstract][Full Text] [Related]
13. Predictors of survival after operation among patients with large cell neuroendocrine carcinoma of the lung.
Eichhorn F; Dienemann H; Muley T; Warth A; Hoffmann H
Ann Thorac Surg; 2015 Mar; 99(3):983-9. PubMed ID: 25596870
[TBL] [Abstract][Full Text] [Related]
14. Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases.
Takei H; Asamura H; Maeshima A; Suzuki K; Kondo H; Niki T; Yamada T; Tsuchiya R; Matsuno Y
J Thorac Cardiovasc Surg; 2002 Aug; 124(2):285-92. PubMed ID: 12167788
[TBL] [Abstract][Full Text] [Related]
15. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence.
Viswanathan AN; Deavers MT; Jhingran A; Ramirez PT; Levenback C; Eifel PJ
Gynecol Oncol; 2004 Apr; 93(1):27-33. PubMed ID: 15047210
[TBL] [Abstract][Full Text] [Related]
16. Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (Nct01282450).
De Ruysscher D; Wanders R; van Baardwijk A; Dingemans AM; Reymen B; Houben R; Bootsma G; Pitz C; van Eijsden L; Geraedts W; Baumert BG; Lambin P
J Thorac Oncol; 2012 Oct; 7(10):1547-55. PubMed ID: 22982655
[TBL] [Abstract][Full Text] [Related]
17. Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.
Naidoo J; Santos-Zabala ML; Iyriboz T; Woo KM; Sima CS; Fiore JJ; Kris MG; Riely GJ; Lito P; Iqbal A; Veach S; Smith-Marrone S; Sarkaria IS; Krug LM; Rudin CM; Travis WD; Rekhtman N; Pietanza MC
Clin Lung Cancer; 2016 Sep; 17(5):e121-e129. PubMed ID: 26898325
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and prognostic factors of pulmonary large cell neuroendocrine carcinoma: A large population-based analysis.
Yang Q; Xu Z; Chen X; Zheng L; Yu Y; Zhao X; Chen M; Luo B; Wang J; Sun J
Thorac Cancer; 2019 Apr; 10(4):751-760. PubMed ID: 30734490
[TBL] [Abstract][Full Text] [Related]
19. Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.
Garg S; Gielda BT; Kiel K; Turian JV; Fidler MJ; Batus M; Bonomi P; Sher DJ
Pract Radiat Oncol; 2014; 4(5):342-348. PubMed ID: 25194104
[TBL] [Abstract][Full Text] [Related]
20. Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer.
Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Bando T; Date H
Ann Surg Oncol; 2014 Aug; 21(8):2546-54. PubMed ID: 24633668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
